At a glance
ClinicalIndex Comparison RecordN/ACompleted· 126 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Post-Market Surveillance Registry for the NeoChord DS1000
In Brief
An observational study for Mitral Valve Insufficiency and 3 related conditions. Completed, enrolled 126 participants across 7 sites in 5 countries.
Detailed Summary
To monitor the long-term performance of the CE Marked NeoChord Artificial Chordae Delivery System
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesFrance, Germany, Italy, Lithuania, Switzerland
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 2013
Enrollment StartMar 2013
Primary CompletionJul 2016
TodayJul 2026
First PostedFeb 5, 2013
Enrollment StartMar 1, 2013
Primary CompletionJul 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.4 years ago